[{"id":"804c573f-8c22-4ca6-9bc7-e76c192b00c2","acronym":"","url":"https://clinicaltrials.gov/study/NCT02950259","created_at":"2021-01-18T14:29:26.884Z","updated_at":"2024-07-02T16:35:21.864Z","phase":"Phase 1","brief_title":"Pre-operative IRX-2 in Early Stage Breast Cancer (ESBC)","source_id_and_acronym":"NCT02950259","lead_sponsor":"Providence Health \u0026 Services","biomarkers":" HER-2","pipe":" | ","alterations":" PD-L1 expression • HER-2 negative","tags":["HER-2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e PD-L1 expression • HER-2 negative"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cyclophosphamide • citoplurikin (IRX-2) • cyclophosphamide intravenous • omeprazole"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 16","initiation":"Initiation: 02/09/2017","start_date":" 02/09/2017","primary_txt":" Primary completion: 05/13/2019","primary_completion_date":" 05/13/2019","study_txt":" Completion: 05/01/2024","study_completion_date":" 05/01/2024","last_update_posted":"2024-01-30"},{"id":"d9161fd5-cfe5-43f2-99b6-9e4b1d2a05cc","acronym":"","url":"https://clinicaltrials.gov/study/NCT03918499","created_at":"2021-01-18T19:16:59.244Z","updated_at":"2024-07-02T16:35:52.602Z","phase":"Phase 1b/2","brief_title":"IRX-2, Cyclophosphamide, and Pembrolizumab in Treating Participants With Recurrent or Metastatic Gastric or Gastroesophageal Junction Cancer","source_id_and_acronym":"NCT03918499","lead_sponsor":"City of Hope Medical Center","biomarkers":" PD-L1","pipe":" | ","alterations":" PD-L1 expression","tags":["PD-L1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e PD-L1 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Keytruda (pembrolizumab) • cyclophosphamide • citoplurikin (IRX-2) • cyclophosphamide intravenous"],"overall_status":"Completed","enrollment":" Enrollment 9","initiation":"Initiation: 04/19/2019","start_date":" 04/19/2019","primary_txt":" Primary completion: 02/09/2023","primary_completion_date":" 02/09/2023","study_txt":" Completion: 02/09/2023","study_completion_date":" 02/09/2023","last_update_posted":"2023-03-23"}]